Naval Lawyer Delivers a Kill Shot to the Left's Uproar Over Trump's Airstrikes...
President Trump Is Right About Tim Walz
Jewish Parents Furious at School Over Muslim Club's Pro-Hamas Display
Trump Was Right to Slam the Brakes on Fuel-Efficiency Standards
Damning Watchdog Report Reveals 'Large-Scale Systemic Failures' Leading to Obamacare Subsi...
Occam's Bazooka
Tech Billionaire Drops $6.25 Billion Donation to Jump-Start Trump Accounts for 25 Million...
A Quick Bible Study Vol. 297: Biblical Time Keeping – BC and AD...
The Dangerous Joy of Christmas: Standing With Persecuted Christians This Season
America First, Christian Nationalism, and Antisemitism
Illegal Alien, Son Arrested for Allegedly Trafficking 75 Firearms
Man Who Set Fire To Train With Victim Inside Face 40 Years in...
Former High-Level DEA Official Charged With Narcoterrorism in Alleged Plot to Aid CJNG...
Florida Man Convicted of Attempted Murder of Two Federal Officers in ATF Raid
DOJ Settlement Forces Constellation to Sell Six Power Plants in $26.6B Calpine Merger
Tipsheet

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’

AP Photo/Pablo Martinez Monsivais, File

Speaking during remarks to a J.P. Morgan healthcare conference this week, Pfizer CEO Albert Bourla openly stated current vaccines the company developed for Wuhan coronavirus offer "limited, if any" protection against contracting current variants of the disease. He then encouraged booster shots. 

The statement from Bourla comes as the Biden administration continues to justify vaccine mandates for federal workers, contractors and private businesses. The Supreme Court heard arguments about President Biden's mandates for private companies and medical workers last week. A ruling is expected soon on the constitutionality of the mandates. 

A number of people who have pointed out the waning efficacy of Pfizer's vaccines, which Bourla touted last year as being "100 percent" effective against contracting or transmitting the virus, have been banned by social media companies. 

Meanwhile, Bourla also announced this week the company is developing a vaccine specific to Omicron. It is expected to be ready in March when health officials predict the latest wave of the mild variant will already be over. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos